Johnson & Johnson Statistics
Total Valuation
JNJ has a market cap or net worth of $394.52 billion. The enterprise value is $407.83 billion.
| Market Cap | 394.52B |
| Enterprise Value | 407.83B |
Important Dates
The next confirmed earnings date is Tuesday, April 15, 2025, before market open.
| Earnings Date | Apr 15, 2025 |
| Ex-Dividend Date | Feb 18, 2025 |
Share Statistics
JNJ has 2.41 billion shares outstanding. The number of shares has decreased by -5.12% in one year.
| Current Share Class | 2.41B |
| Shares Outstanding | 2.41B |
| Shares Change (YoY) | -5.12% |
| Shares Change (QoQ) | -0.03% |
| Owned by Insiders (%) | 0.05% |
| Owned by Institutions (%) | 73.25% |
| Float | 2.41B |
Valuation Ratios
The trailing PE ratio is 28.27 and the forward PE ratio is 15.49. JNJ's PEG ratio is 2.91.
| PE Ratio | 28.27 |
| Forward PE | 15.49 |
| PS Ratio | 4.44 |
| Forward PS | 4.36 |
| PB Ratio | 5.51 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 19.88 |
| P/OCF Ratio | 16.26 |
| PEG Ratio | 2.91 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 13.62, with an EV/FCF ratio of 20.55.
| EV / Earnings | 28.99 |
| EV / Sales | 4.59 |
| EV / EBITDA | 13.62 |
| EV / EBIT | 18.04 |
| EV / FCF | 20.55 |
Financial Position
The company has a current ratio of 1.11, with a Debt / Equity ratio of 0.53.
| Current Ratio | 1.11 |
| Quick Ratio | 0.78 |
| Debt / Equity | 0.53 |
| Debt / EBITDA | 1.26 |
| Debt / FCF | 1.91 |
| Interest Coverage | 29.94 |
Financial Efficiency
Return on equity (ROE) is 20.06% and return on invested capital (ROIC) is 13.55%.
| Return on Equity (ROE) | 20.06% |
| Return on Assets (ROA) | 8.13% |
| Return on Invested Capital (ROIC) | 13.55% |
| Return on Capital Employed (ROCE) | 17.41% |
| Revenue Per Employee | $643,164 |
| Profits Per Employee | $101,854 |
| Employee Count | 138,100 |
| Asset Turnover | 0.51 |
| Inventory Turnover | 2.29 |
Taxes
In the past 12 months, JNJ has paid $2.62 billion in taxes.
| Income Tax | 2.62B |
| Effective Tax Rate | 15.71% |
Stock Price Statistics
The stock price has increased by +3.64% in the last 52 weeks. The beta is 0.46, so JNJ's price volatility has been lower than the market average.
| Beta (5Y) | 0.46 |
| 52-Week Price Change | +3.64% |
| 50-Day Moving Average | 158.51 |
| 200-Day Moving Average | 156.22 |
| Relative Strength Index (RSI) | 55.63 |
| Average Volume (20 Days) | 8,713,870 |
Short Selling Information
The latest short interest is 24.87 million, so 1.03% of the outstanding shares have been sold short.
| Short Interest | 24.87M |
| Short Previous Month | 18.35M |
| Short % of Shares Out | 1.03% |
| Short % of Float | 1.03% |
| Short Ratio (days to cover) | 2.58 |
Income Statement
In the last 12 months, JNJ had revenue of $88.82 billion and earned $14.07 billion in profits. Earnings per share was $5.79.
| Revenue | 88.82B |
| Gross Profit | 61.79B |
| Operating Income | 22.60B |
| Pretax Income | n/a |
| Net Income | 14.07B |
| EBITDA | 29.94B |
| EBIT | 22.60B |
| Earnings Per Share (EPS) | $5.79 |
Balance Sheet
The company has $24.52 billion in cash and $37.83 billion in debt, giving a net cash position of -$13.31 billion or -$5.52 per share.
| Cash & Cash Equivalents | 24.52B |
| Total Debt | 37.83B |
| Net Cash | -13.31B |
| Net Cash Per Share | -$5.52 |
| Equity (Book Value) | 71.49B |
| Book Value Per Share | 29.70 |
| Working Capital | 5.57B |
Cash Flow
In the last 12 months, operating cash flow was $24.27 billion and capital expenditures -$4.42 billion, giving a free cash flow of $19.84 billion.
| Operating Cash Flow | 24.27B |
| Capital Expenditures | -4.42B |
| Free Cash Flow | 19.84B |
| FCF Per Share | $8.23 |
Margins
Gross margin is 69.56%, with operating and profit margins of 25.45% and 15.84%.
| Gross Margin | 69.56% |
| Operating Margin | 25.45% |
| Pretax Margin | 18.79% |
| Profit Margin | 15.84% |
| EBITDA Margin | 33.71% |
| EBIT Margin | 25.45% |
| FCF Margin | 22.34% |
Dividends & Yields
This stock pays an annual dividend of $4.96, which amounts to a dividend yield of 3.03%.
| Dividend Per Share | $4.96 |
| Dividend Yield | 3.03% |
| Dividend Growth (YoY) | 4.20% |
| Years of Dividend Growth | 63 |
| Payout Ratio | 85.66% |
| Buyback Yield | 5.12% |
| Shareholder Yield | 8.15% |
| Earnings Yield | 3.57% |
| FCF Yield | 5.03% |
Analyst Forecast
The average price target for JNJ is $170.75, which is 4.30% higher than the current price. The consensus rating is "Buy".
| Price Target | $170.75 |
| Price Target Difference | 4.30% |
| Analyst Consensus | Buy |
| Analyst Count | 17 |
| Revenue Growth Forecast (5Y) | 3.61% |
| EPS Growth Forecast (5Y) | 17.45% |
Stock Splits
The last stock split was on June 13, 2001. It was a forward split with a ratio of 2:1.
| Last Split Date | Jun 13, 2001 |
| Split Type | Forward |
| Split Ratio | 2:1 |
Scores
JNJ has an Altman Z-Score of 4.23 and a Piotroski F-Score of 6.
| Altman Z-Score | 4.23 |
| Piotroski F-Score | 6 |